Best Startup
At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based Director operating in the Medical space. If you think a Director is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Paul Agapow
Health Informatics Director of AstraZeneca
Originally a labcoat-wearing biochemist and immunologist, Paul fell sideways into using computers for biology, at first for evolutionary biology and infectious disease. In more recent years, his work has focused on precision medicine and biomedical analytics.
Follow Paul Agapow:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Vincenzo Garzya
Patient Centricity Excellence Director of AstraZeneca
Follow Vincenzo Garzya:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Claus Bendtsen
Executive Director of AstraZeneca
Claus Bendtsen heads Quantitative Biology as part of Discovery Sciences within AstraZeneca. His department provides global support in areas of informatics, mathematical modelling, image analytics and non-clinical statistics. Prior to joining AstraZeneca he held positions at Novartis and Merck & Co. Earlier in his career he co-founded three start-ups and worked in academia. He holds a Ph.D. in applied mathematics and an MBA.
Follow Claus Bendtsen:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Sheena Behn
Global Supply Director of AstraZeneca
Sheena Behn is an established global leader in the Pharmaceutical Industry with significant supply chain, manufacturing and development experience and expertise. She has worked at AstraZeneca for 20 years. Sheena is currently VP Therapy Area Supply (for CVRM/INA Therapy Areas) in Operations for AstraZeneca, and the Operations Executive Sponsor for Risk, based in the UK. She was previously based in Gothenburg as VP R&D Supply Chain (2013-2015), running the global group for Clinical Supply at AZ; and before that VP for Wuxi Manufacturing site for 3 years, based in China (2010-2012). Sheena is a Pharmacist who started her career working in London hospitals, before working in pharmaceutical development with GSK and then AZ before joining Operations in 2007.
Follow Sheena Behn:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Matthew Bonam
Pharmaceutical Project Director of AstraZeneca
Follow Matthew Bonam:
About AstraZeneca, AstraZeneca, AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Louise Almond
Associate Director, Process Sciences of Allergan
Follow Louise Almond:
About Allergan, Pharmaron: Allergan is a global pharmaceutical company.
Chris Bonnett
Projects Director of GE Healthcare
Chris Bonnett is a project director at GE Healthcare.
Follow Chris Bonnett:
About GE Healthcare: GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care.
Ilaria Grizzi
Director, System Integration of Illumina
Follow Ilaria Grizzi:
About Illumina: Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Duncan Anderson
Managing Director of Willis Towers Watson
Follow Duncan Anderson:
About Willis Towers Watson: Willis Towers Watson is a global advisory and solutions company that helps clients around the world turn risk into a path for growth.
Paul Morris
Non Executive Director of Willis Towers Watson
Follow Paul Morris:
About : Willis Towers Watson is a global advisory and solutions company that helps clients around the world turn risk into a path for growth.
Victoria Stewart
Director Of Communications of Abingworth
Victoria has more than 18 years experience in the life sciences sector. She manages and advises on Abingworth’s public relations strategy in Europe and the US and provides support to portfolio companies. Victoria joined Abingworth in 2000 from PJB Publications, where she was Biotechnology Editor of Scrip World Pharmaceutical News. Victoria has held editorial positions at Chemistry in Britain and the Financial Times, where she covered Pharmaceutical Business News, Biotechnology Business and Medical Device Business News. She has a degree in Biological Chemistry from the University of Kent at Canterbury.
Follow Victoria Stewart:
About Abingworth: Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs.
Elena Fernandez Kleinlein
Sr. Director Consumer Scientific Innovation of Johnson & Johnson
Elena is the Senior Director of Consumer Scientific Innovation at Johnson & Johnson Innovation. Her main responsibilities are scouting and evaluating early stage technologies and opportunities and managing external partnerships for the strategic areas within the Consumer Sector. Prior to this role, Elena was the Senior Director of R&D Global Topical Health Care for Johnson & Johnson Consumer & Personal Products. In this position, she was responsible for seeking innovative products and claims pipelines within the franchise and oversaw the product development program for iconic brands such as Band-Aid Adhesive Bandages, Johnson & Johnson’s Red Cross and other regional brands like Compeed, Neosporin and Bengay. Elena has grown in the Johnson & Johnson Family of Companies, previously holding roles of Senior Director R&D EMEA Topical Health, performing as the Worldwide Director Women’s Health R&D, and Manager Baby & Kids R&D EMEA for Johnson & Johnson in Germany. These positions have provided her an in-depth knowledge in Research & Development across different groups as well as launch & commercialization experience of different product categories. She has filed several patents. Elena holds a BS and MS in Food Science & Technology from Technical University Munich, Germany.
Follow Elena Fernandez Kleinlein:
About Johnson & Johnson: Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.
George Sutherland
Company Secretary & Non-Executive Director of TestCard Ltd
An experienced Company Director and a Fellow of the Institute of Directors who has demonstrated many years of success working with major fast moving consumer goods (FMCG) and Medical companies. Personally managed business with most of the major retailers and has many years of experience in dealing with the NHS and Medical markets. Experience in raising corporate finance, pre and post IPO.
Follow George Sutherland:
About : TestCard is the medical technology company behind the eponymous at-home test kit. A partnering mobile app delivers immediate results.
Anne Lenihan
Director Regulatory Affairs of Pfizer
Follow Anne Lenihan:
About Pfizer: Pfizer provides access to safe and effective and affordable medicines and health care services.
Jeremy Farrar
Director of Wellcome Trust
Former Director, Oxford University Clinical Research Unit, Vietnam, with research interests in infectious diseases, tropical health and emerging infections. 2013, joined the Wellcome Trust; currently, Director. Fellow: Academy of Medical Sciences; The Royal Society. Recipient of numerous awards and honours, including: appointed OBE for services to Tropical Medicine (2005); Memorial Medal and Ho Chi Minh City Medal, Government of Vietnam. Named 12th in the Fortune list of 50 World’s Greatest Leaders in 2015.
Follow Jeremy Farrar:
About Wellcome Trust: Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health.
Lynsey Flitton
Associate Director Labeling Strategy Europe of AbbVie
Follow Lynsey Flitton:
About AbbVie: AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.
Rafael López Schietekat
Founder & Managing Director of Diagnostikare
Follow Rafael López Schietekat:
About Diagnostikare: The first data-driven patient-centric virtual primary care platform in Mexico.
Simon Barter
Commercial Director of Proveca
Simon Barter is a commercial director at Proveca. Simon is an experienced pharmaceutical professional having held several significant senior level roles including the head of Global Marketing capability for AstraZeneca, the head of the Global Commercial Innovation function. He has a track record of delivery in global marketing, innovation, corporate and portfolio strategy and operating company delivery. He has broad therapeutic experience having led the commercial therapy areas for Pain, Anaesthesia, Infection and Oncology. Simon has lived and worked across several European countries in sales and marketing roles, amassing first hand experience of several healthcare systems. Simon has a BSc (Hons) from London University and a Masters in Science of Management from Boston University.
Follow Simon Barter:
About Proveca: Proveca Ltd is a UK based pharmaceutical company.
Andrew Shepherd
Co-Founder & Managing Director of Omega Diagnostics
Andrew Shepherd is the Founder and Managing Director of Omega Diagnostics Limited. He is responsible for corporate strategy, general management, sales and marketing and technical direction. He has been involved in the medical diagnostics industry for the last 35 years. He started his career in 1974 by holding technical positions at G.D. Searle Limited and then attended university, graduating with a Bachelor of Science in Biology. He then moved into a sales and marketing position at Cambridge Life Sciences plc in 1981, before establishing his first diagnostics company, Cambridge Biomedical Limited in 1982. In 1986 he moved to Scotland to join Bioscot Limited and shortly afterwards, established Omega. Shepherd used his technical experience and knowledge of exporting to oversee the growth of the export of Omega products to exceed £2 million per annum. Omega now exports to over 100 countries around the world, and he travels regularly to many of the countries in which Omega customers are based. Shepherd is an active member of a number of relevant trade associations and was a member of the Scottish Exports Forum, a body which reported to the Scottish Parliament to oversee and guide the export activity of Scottish Development International. Mr Shepherd was also a member of the Bill & Melinda Gates Foundation’s (BMGF) Global Health Diagnostics Forum, which provides direct guidance to BMGF in advising on future investments in worldwide diagnostics programmes for developing countries.
Follow Andrew Shepherd:
About Global DX Ltd, Omega Diagnostics: Omega Diagnostics provides IVD products for use in hospitals, blood banks, clinics, and laboratories.
Tim Luker
Senior Director, External Innovation, Global External R&D of Eli Lilly
Follow Tim Luker:
About Eli Lilly: Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.
Derek Marren
Director – Research IT – Global TA & Biology systems & Data Integration of Eli Lilly
Follow Derek Marren:
About AstraZeneca, Eli Lilly: Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.
Steve Lane
Commercial Director UK & Europe of Quanta
Follow Steve Lane:
About Quanta: Quanta develops an advanced haemodialysis systems for use in the home and clinic.
Kruti Popat
Director, Customer Insights & Engagement of Galapagos
Follow Kruti Popat:
About Galapagos: Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.
Ian Mills
Director of Software Engineering and Co-Founder of Clinpal
Ian has been directly involved in the development of some of the leading, and most advanced EDC systems brought to market in the last 15 years. At eClinicalHealth, he continues to lead from the front by supporting clients integrate and extend their eClinical solutions. Ian is an expert in agile software development methods, and besides his hands-on technical prowess he has take the lead in ensuring organizations he works with have bullet proof auditability throughout their product development lifecycle. All work carried out at eClinicalHealth follows either our own rigorous agile Software Development LifeCycle, or, if preferred our sponsors. Ian’s EDC products have been used globally by companies such as Roche, Novartis, Merck and Johnson & Johnson. Ian is a master of CDISC standards – ODM specifically – as well as Web technologies for regulated industries that include; RUP, XP, UML, SCRUM, Agile Development, JEE (JPA, JSF, JSP, JMS, JMX, JTA), Spring Framework, Eclipse, Hibernate, Tapestry, Web Services, JavaScript, Ajax, GWT, JQuery, SQL (Oracle, DB2, MySQL), XML, NoSQL Databases (ObjectStore, Mongo, CouchDB), C/C++, Groovy, Python. Besides Ian’s computing language proficiency, Ian is also fluent in both English and German.
Follow Ian Mills:
About Clinpal: Clinpal is a leading cloud-based digital patient recruitment and engagement platform.
Tarlochan Toor
Medical Director & Co-founder of MedicSpot
Follow Tarlochan Toor:
About MedicSpot: MedicSpot gives patients convenient and quick access to healthcare using the latest advancements in telemedicine
Ann Maitland
Group Director Global Operations of BSN Medical
Ann Maitland joined BSN medical in 2001. Beginning her career with Smith & Nephew Textiles in 1974 within the Surgical Dressings business, she held various positions within a manufacturing capacity before being promoted to Manufacturing Director of the Medical Fabrics Division in 1998. Following the formation of BSN medical in 2001, Ann had subsequent responsibility as VP Operations within the Orthopaedics global business unit. In 2006, she was appointed Senior VP responsible for Global Operations. She continues to manage the operations side of the business today. In her role as EVP Global Operations, Ann is responsible for Global Logistics, Global Procurement, Global Supply Chain and Advanced Manufacturing Engineering.
Follow Ann Maitland:
About BSN Medical: BSN Medical is a global leader in the worldwide healthcare market specialising in the areas of Compression Therapy.
Danilo Casadei Massari
Board of Directors of TargEDys
Follow Danilo Casadei Massari:
About BCD Bioscience, Nemysis: TargEDys develops functional food, medical food and medical products to harness the microbiota’s ability to regulate appetite.
Andrew Gore
Non Executive Director of Genmed
Follow Andrew Gore:
About Genmed: Genmed is a provider of vendor-neutral, flexible, scalable managed services to the NHS, Health Boards, and private healthcare organizations.
Vibhor Gupta
Director and Founder of Pangaea Data
Vibhor is an entrepreneur in residence at Nexgen Capital Ventures where he is involved in deal flow and leading creative technological opportunties within Life Sciences following his breadth of experience in industry and academia over the last 16 years. Prior to this role, Vibhor has served in various positions ranging from technical bioinformatics roles, sales (of software technology products) and executive management. Vibhor started and built the European business for Quantum Secure, which was an enterprise software solutions provider and was successfully acquired in 2015. Most recently he served as a Senior Vice President at Seven Bridges Genomics which provides cloud (SaaS) based bioinformatics solutions for the Life Sciences industry. Vibhor has also worked as a management and technology consultant for Deloitte. His academic career focused on bioinformatics, epigenetics and molecular biology studies in oncology and infectious diseases. Vibhor has access to an extensive network in the industry and was recently honoured as an advisor to two prominent organisations, HealthEx and FrontLine Genomics. He was also a Technology Lead on ASIS’s UK committee, which is the largest professional body for CSOs and CISOs in the world.
Follow Vibhor Gupta:
About Pangaea Data: Pangaea Data provides a machine learning-based software solution making scientific and clinical data more meaningful.
Katherine Ward
Chief Commercial Officer, Managing Director UK & Europe of Healthy.io
Follow Katherine Ward:
About Healthy.io: Healthy.io converts smartphone cameras into a clinical grade medical device.
Mathieu de Beaumont
Co-Founder / Director of Dementech
Co-Founder of Dementech Neurosciences
Follow Mathieu de Beaumont:
About : Neurology & Psychology experts
Michel Rabhi
Founder and Director of Dementech
Owner and Director at Dementech Neurosciences
Follow Michel Rabhi:
About : Neurology & Psychology experts
Raj Vora
Founder & Managing Director of Revital
Follow Raj Vora:
About Revital: Revital is an independent company with a mission to care for the wellbeing and health of our customers.
Mark Jopling
Clinical Director of DocTap
Mark has a wealth of GP experience in both the NHS and private practice. Mark ensures that DocTap meets the highest standards of clinical safety, governance and compliance. He is thrilled to be helping provide convenient, affordable and above all excellent GP services to people in London.
Follow Mark Jopling:
About DocTap: DocTap provide convenient, expert GP care from their network of central London clinics.
Richard Durbin
Informatics Director of Congenica
Richard is a Group Leader of the Human Genetics Programme at the Wellcome Trust Sanger Institute, a Fellow of the Royal Society, and a Member of EMBO. A pioneer in the industry, he has developed sequence data analysis tools that are now standards in the field. His current research focuses on human genetic variation by large scale genome-wide re-sequencing. Richard has led the international 1000 Genomes Project and the UK10K Genome Project, and has made significant contributions to the Ensembl resource for vertebrate genome annotation, and the TreeFam and Pfam databases.
Follow Richard Durbin:
About Congenica: Congenica is a biotechnology company that provides a diagnostic decision support platform.
Matthew Hurles
Scientific Director of Congenica
Matt is Senior Group Leader at the Wellcome Trust Sanger Institute and a leader in the Deciphering Developmental Disorders, 1000 Genomes and UK10K projects. He has pioneered the analysis of whole exomes in clinically relevant disorders that previously failed diagnostic methods, and has led an initiative to characterise structural variation in the human genome, and integrate this knowledge into disease and population genetic studies. Matt has been awarded the Balfour Lecture by the Genetics Society and the Crick Lecture prize for accomplishments in genetics by the Royal Society.
Follow Matthew Hurles:
About Congenica: Congenica is a biotechnology company that provides a diagnostic decision support platform.
Philip Beales
Medical Director of Congenica
Phil is a consultant physician and Professor of Medical and Molecular Genetics at the UCL Institute of Child Health (ICH), an NIHR Senior Investigator, an Honorary Consultant in Clinical Genetics at Great Ormond Street Hospital (GOSH) and the lead on Personalised Medicine for UCL. He is an internationally recognized expert in the genetics and pathogenesis of ciliopathies and pioneering use of next generation sequencing in mapping disease genes in this area.
Follow Philip Beales:
About Congenica: Congenica is a biotechnology company that provides a diagnostic decision support platform.
Luke Hares
Technology Director of CMR Surgical
Before co-founding CMR he worked for product design companies in the UK and the US, where he worked on medical devices, robotics, ASIC developments and consumer products. Luke believes the best devices are created by combining a detailed knowledge of the unmet needs of the users with the creative application of a broad knowledge of available technology. Regular contact and interaction with the users of the product is essential for this process. Luke is responsible for leading the CMR technology team and has overall responsiblilty for the technology strategy of the company. He is accustomed to championing ideas, communicating technically complex ideas and designing and managing the development of complex systems.
Follow Luke Hares:
About CMR Surgical: CMR Surgical is developing the next-generation surgical robotic system for minimal access surgery.
Elaine Jones
Finance Director of Circle Health
Elaine Jones is a finance director at Circle Health.
Follow Elaine Jones:
About Circle Health: Circle Health is a provider of health care service with investigation and treatment of diseases.
Soren Krogsgaard Thomsen
Co-Founder, CEO and Managing Director of BioMe Oxford
Soren is a medical scientist at the University of Oxford, with a background in the natural sciences and genetics research. He previously worked as a consultant for pharma and OBR consulting, and has published on his experiences as an academic entrepreneur. Soren’s current research is focused on translating large-scale genetic data into mechanisms for disease to inform new therapeutic strategies. He dreams of one day enabling similar population-wide microbiome studies using the platform technology under development at BioMe Oxford Ltd.
Follow Soren Krogsgaard Thomsen:
About BioMe Oxford, Vertex Pharmaceuticals: Unlocking your gut microbiome by developing a medical device for targeted and non-invasive sampling
Shankar Balasubramian
Co-Founder and Director of Cambridge Epigenetix
Sir Shankar is Founder of two companies and the principal inventor of the leading next generation human genome sequencing technology core to all Illumina sequencing platforms, estimated to be worth >$30BN. Sir Shankar’s technology has made routine, accurate, low-cost sequencing of human genomes a reality, has revolutionised biology and accelerated the development of genomic personalised medicine. Sir Shankar is the Herchel Smith Professor of Medicinal Chemistry at the University of Cambridge and Senior Group Leader at the Cancer Research UK Cambridge Institute. His awards include the Royal Medal (2018), the RoyalSociety Mullard Award (2009), The BBSRC Innovator of the year (2010) and the Tetrahedron Prize (2013). He is a Fellow of the Royal Society, the Academy of Medical Sciences and a member of EMBO.
Follow Shankar Balasubramian:
About Ahren Innovation Capital, Cambridge Epigenetix: Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
Martin Murphy
Associate Director of Cambridge Epigenetix
Follow Martin Murphy:
About Cambridge Epigenetix: Cambridge Epigenetix is using epigenetics to reduce several routine & important diagnostic tests for common cancers to a simple blood draw.
Nicholas Heaton
senior Director, Business Development of SHL Medical
Follow Nicholas Heaton:
About SHL Medical: SHL designer, developer, and manufacturer of advanced drug delivery devices such as autoinjectors, pen injectors, and inhaler systems.
Shash Patel
Director & Information Risk Management & Privacy of Air Products and Chemicals
In this role he is responsible for overall Information Governance, including Risk assessments and response activities which encompass the evaluation, mitigation and reporting of information and privacy risks facing the Company. This includes leading an enterprise wide Information Risk Management (IRM) program covering Intellectual Asset Protection (IAP), Data Privacy (acting as the Data Privacy Officer) and Enterprise Records Management. He is currently Co-Chair of Spectrum Europe (The European chapter of Air Products’ LGBT+ Employee Resource Group) and is on the Tech Partnership Degrees Employer Board. His volunteering activities are focused on STEM related mentoring, education and awareness with Tech Partnership Degrees and charities such as SATRO and TeenTech. Previous business roles include in the Air Products’ Corporate Risk Office, as Director of Intellectual Asset Protection. Prior to that, he has held various IT leadership roles including Global Director of Business Relationship Management and Director of IT Security, Compliance and Risk Management. Over his career he has lived and worked in Germany, the Netherlands and the United States of America.
Follow Shash Patel:
About Air Products and Chemicals: Air Products supplier of industrial gases and equipment, specialty and intermediate chemicals, and environmental and energy systems.
Ajan Reginald
Executive Director & Co-Founder of Cell Therapy
Follow Ajan Reginald:
About Celixir, Cell Therapy: Cell Therapy Ltd is a British pioneer in Regenerative Medicine.
Hugh Dunlop
Finance Director of Medical Research Council
Responsible for financial strategy and planning; for monitoring, controlling and accounting for expenditure and resources.Provides information and advice to assist corporate decision-making.
Follow Hugh Dunlop:
About Medical Research Council: At the beginning of the twentieth century, tuberculosis was one of the UK’s most urgent health problems.
Tony Peatfield
Corporate Affairs Director of Medical Research Council
Plans and delivers a programme of communication and public affairs activities to foster dialogue with the public and other stakeholder groups, show the link between medical research and health, and facilitates our scientists’ public engagement work.Leads the development of corporate governance.Provides a focus for national policy development, including legislation, research ethics, and associated networking with and influencing of key external stakeholders
Follow Tony Peatfield:
About Medical Research Council: At the beginning of the twentieth century, tuberculosis was one of the UK’s most urgent health problems.
Sandy Bulger
Director of Major Projects of Medical Research Council
Responsible for delivery of major projects for the MRC and for project management standards. Ensures that MRC investment in major capital programmes is managed effectively.Leads the MRC contribution to the delivery of the Francis Crick Institute and other capital projects.Responsible for ensuring the MRC Estate is well-managed and reflects research requirements.
Follow Sandy Bulger:
About Medical Research Council: At the beginning of the twentieth century, tuberculosis was one of the UK’s most urgent health problems.
Sally Smith
HR Director of Medical Research Council
Follow Sally Smith:
About Medical Research Council, Medical Research Council: At the beginning of the twentieth century, tuberculosis was one of the UK’s most urgent health problems.
Eric Beard
Director of EOS Imaging
Eric Beard has vast operational experience in medical technology and patient home self care. He joined Baxter Healthcare in 1975, where he pursued an international career, principally in North America, Asia pacific and Europe. He was in charge of Baxter’s renal products in various countries and regions and in 1999 asumed global responsibility for the business. In 2001, he was appointed president of Baxter EMEA. Prior to joining Cellnovo he was with Sorin Group as President International in charge of worldwide sales and marketing.
Follow Eric Beard:
About CellNovo, EOS Imaging: EOS imaging designs, develops, and markets EOS®, a revolutionary and patented medical imaging system, based on technology.
Chris Jones
Non Executive Director & Special Advisor of MediSieve
Chris Jones joined Elasmogen as Executive Chairman in 2016.
Follow Chris Jones:
About Elasmogen, MediSieve, Mologic: MediSieve is a therapeutics company developing a platform technology for the treatment of blood-borne diseases.
Berwyn Clarke
Non Executive Director of PBD Biotech
Berwyn is an experienced senior manager in the pharmaceutical and diagnostics industry. In 2005 he founded a new diagnostics company in the UK, Lab21 Limited, prior to establishing network of diagnostics industry interests in 2013. He is currently Chairman of NALIA Systems Ltd and PBD Biotech Ltd and non-executive director at Protein Logic. He is currently also Entrepreneur-in-Residence at Cardiff University and is a senior advisor to the Welsh Government Life Sciences sector.
Follow Berwyn Clarke:
About Glyconics, PBD Biotech: PBD Biotech specialises in novel phage-based diagnostics for the veterinary, agriculture and human health sectors
Ben Swift
Director of Research and Development of PBD Biotech
Follow Ben Swift:
About PBD Biotech: PBD Biotech specialises in novel phage-based diagnostics for the veterinary, agriculture and human health sectors
Duncan Hynd
Managing Director of Advanced Oncotherapy
Follow Duncan Hynd:
About Advanced Oncotherapy, Hynd Healthcare: Advanced Oncotherapy is a medical technology company providing advanced radiotherapy systems for the treatment of common and rare cancers.
Julie Walters
Founder & Executive Director of Xperiome
Follow Julie Walters:
About Xperiome: Xperiome is a global healthtech company that delivers deep insights in rare disease experiences
Ozgur Tuncer
CEO & Executive Director of Stablepharma Ltd
Ozgur Tuncer CEO & Executive Director – two decades of experience in the biopharmaceutical industry including working for blue chip companies such as Pfizer, IQVIA and Pharmacia. Most recently, he was Global Vice President in IQVIA, and strategic adviser to life sciences investors. In addition to his role in Stablepharma, Özgür is an Investment Partner with Ascension Ventures.
Follow Ozgur Tuncer:
About Stablepharma Ltd: An innovative Biotech, developing a wide range of reformulated thermostable and fridge free StablevaX vaccines
Andy McClure
Marketing and Proposition Director of AXA PPP Healthcare
Follow Andy McClure:
About AXA PPP Healthcare: AXA PPP Healthcare aim is to help people in every aspect of their health.
Elodie Siney
Director and Co-Founder of VisusNano
Elodie is a research scientist with expertise in human stem cells, completed the integrated PhD programme at the University of Southampton specialising in human stem cells for translational research. Elodie worked in an SME as a chemical analyst and has experience in clinical trials.
Follow Elodie Siney:
About VisusNano: Revolutionising Treatment for Cataracts
Morgan Page
Co-founder & Technical Director of Dual Good Health
Follow Morgan Page:
About Dual Good Health: Using virtual reality to train more people how to save lives
Gil McVean
Co Founder & Director of Genomics
Gil McVean is Professor of Statistical Genetics at the University of Oxford and Head of Bioinformatics and Statistical Genetics at the Wellcome Trust Centre for Human Genetics. After an undergraduate training in Zoology, he obtained a PhD with Laurence Hurst in Cambridge and worked with Brian and Deborah Charlesworth in Edinburgh before joining Oxford in 2000. His research focuses on understanding the molecular and evolutionary processes that shape genetic variation in populations and the relationship between genetic variation and phenotype. He has made contributions to our understanding of areas including recombination hotspots, historical patterns of natural selection, the male mutation rate, human genetic variation, the role of HLA in complex disease and genealogical processes. He has played a leading role in the HapMap and 1000 Genomes Projects and currently works on organisms from HIV to malaria.
Follow Gil McVean:
About Genomics: Genomics plc aiming to lead the genomic transformation of healthcare.
Peter Blencowe
Managing Director and Co-Founder of Bluecrest Wellness
Peter Blencowe is the Managing Director and Co-founder of Bluecrest Health Screening.
Follow Peter Blencowe:
About Bluecrest Wellness: Bluecrest Wellness is a privately run health screening company founded in the UK in 2012.
Alex Higman
Operations Director and Co-Founder of Bluecrest Wellness
Alex Higman is the operations director and co-founder of Bluecrest Health Screening.
Follow Alex Higman:
About Bluecrest Wellness: Bluecrest Wellness is a privately run health screening company founded in the UK in 2012.
Oliver Kessler
Founder, Medical Director and Chief Medical Officer of Orthox Ltd.
Oliver Kessler is a practising knee surgeon based in Zurich with a strong track record of biomaterials research and a focus on meniscal and cartilage repair systems and joint kinematics. He spent 6 years at Stryker Orthopaedics as Director of Orthobiologics supervising a major meniscal tissue engineering programme. He has extensive contacts within both the orthopaedic industry and the surgical community and is responsible for overseeing clinical development of Orthox’s product pipeline.
Follow Oliver Kessler:
About Orthox Ltd.: Orthox develops tissue regenerative implants that address large injuries to cartilage tissues in which early osteoarthritis may be present.
Sarah Nurse
Operations Director of Orthox Ltd.
Sarah Nurse is an experienced Operations and Finance Director with the skills to create and manage a corporate services function. She has over 20 years experience incorporating start ups and growing SME companies; ensuring full financial and management accounting control, and managing human resource, information technology and quality assurance functions in both the public and private sectors.
Follow Sarah Nurse:
About Orthox Ltd.: Orthox develops tissue regenerative implants that address large injuries to cartilage tissues in which early osteoarthritis may be present.
Mark Lait
Vice-president & Managing Director of Water-Jel Technologies
Mark joined the company in 1992 as the WaterJel distributor for the UK and Ireland; his geographic responsibility increased in 2003 to all international business. Prior to 1992, Mark was a director of a number of medium-sized medical companies with manufacturing bases in UK, U.S. and Australia. With a background in medical engineering, HND MEng, he has been responsible for the design and development of unique technologies used in pediatric / neonatal care and the treatment of thermal injuries. Based at WaterJel’s UK office, Mark is multilingual and has lived and worked in several countries, contributing to his extensive international business experience.
Follow Mark Lait:
About Water-Jel Technologies: Water-Jel is a manufacturer of branded and private label specialty medical products.
Matthew Ainslie
Director DevOps & Cloud Engineering of PAREXEL
Matthew Ainslie serves as director of cloud engineering and devops at PAREXEL.
Follow Matthew Ainslie:
About PAREXEL: PAREXEL is a biopharmaceutical services company that focuses on the development and commercialization of new medical therapies worldwide.
Daniel Broughton
Director of Dr. Fox
Follow Daniel Broughton:
About : Online Doctors and Pharmacy Service
Tony Steele
Medical Director of Dr. Fox
Follow Tony Steele:
About : Online Doctors and Pharmacy Service
Dr Edward Bosonnet
Director of Primary Care of Medefer
Follow Dr Edward Bosonnet:
About Medefer: At Medefer, we want to be the world’s most patient-focused virtual health service
Andrew Newell
Managing Director & Founder of Cipher Surgical
Andrew Newell is Founder & Managing Director at Cipher Surgical
Follow Andrew Newell:
About Cipher Surgical, Exomedica: Cipher Surgical is a medical device company established to design, patent, and globally market its laparoscopic medical device.
Mick Hunter
Chief Scientific Officer & Director of Development of Atopix Therapeutics
Dr Mick Hunter has responsibility for drug discovery and development in Atopix. He has over 28 years experience in Pharmaceutical and Biotech R&D. He has spent the past 12 years working on the discovery and development of antinflammatory and respiratory drugs. He is also Director of Discovery at Oxagen Ltd. Mick has led Atopix CRTH2 antagonist discovery and development program from concept to Phase IIb. Less Mick has experience of leading teams to identify IND candidates and managing them through early clinical development. He is familiar with regulatory environments and has managed biological pilot plants for GMP manufacture. Prior to joining Atopix, Mick held positions at Oxagen Ltd, British Biotech Pharmaceuticals (now Vernalis PLC) and at Searle Pharmaceuticals.
Follow Mick Hunter:
About Atopix Therapeutics: Atopix Therapeutics Limited is a privately held, clinical-stage, biopharmaceutical company based in Oxford, UK
Ian Jones
Property Director of The Naked Deli
Follow Ian Jones:
About The Naked Deli: THE place to go for Clean, Healthy, nutritious Natural foods, smoothies, GF refined sugar free treats, smoothies and cold pressed juices.
Alex Papanikolaou
Founder and Technical Director of Freedom One Life
Born with Athetoid cerebral palsy, from a young age, I have been determined that whatever physical difference I have, it isn’t going to stop me from living and experiencing life in the way that I want, and from doing the things I want to do in the way that I want to do them. My experiences and insights have led me to starting Freedom One Life, to inspire and empower people living with a physical disability. Enabling people around the world to expect and demand the same standard of living and mobility that a non-disabled person takes for granted. The first product is a game changing next generation power wheelchair. I have worked in national retail stores, driven around the country and travelled around the world with my power wheelchair. I have consulted internationally on access, equality, inclusiveness and I’ve been part of progressive change towards creating more inclusive environments.
Follow Alex Papanikolaou:
About Freedom One Life: Redefining mobility
Albert Nicholl
Managing Director of Freedom One Life
Follow Albert Nicholl:
About Freedom One Life: Redefining mobility
Banafshe Larijani
Co-founder, Joint Managing Director and CSO of Fastbase Solutions
Banafshe Larijani holds a PhD in Molecular Cell Biology and Biochemistry, Amherst College, and the University of Massachusetts at Amherst, Massachusetts, USA. Head of Cell Biophysics Laboratory since 2002 at Cancer Research UK, she was appointed Senior Scientist in 2012 and in 2014 was awarded the Ikerbasque Research Professorship. She holds adjunct professorships with University of Bath (UK), Stony Brooks University NY and University of Massachusetts, Amherst MA, (USA). Her laboratory is a cutting-edge cross-disciplinary platform, which draws upon the physical sciences to develop novel avenues for investigation of biological processes in signalling. The outcomes of her fundamental research involving the application of quantitative imaging (FRET-FLIM) for investigating molecular mechanisms of various oncoproteins have resulted in their application to clinical objectives. Cell Biophysics is now at the Biophysics Institute Insituto Biofisika) and Research Centre for Experimental Marine Biology and Biotechnology (PiE) in Bilbao, Spain.
Follow Banafshe Larijani:
About Fastbase Solutions: Fastbase Solutions is a cancer diagnostics platform.
Anya Roy
Managing Director of Syrona Health
Anya Roy is the co-founder of Syrona Health.
Follow Anya Roy:
About Syrona Health: Syrona Health is a personalised digital health platform for Chronic Gynaecological/Uterine Conditions like Endometriosis, PCOS etc.
Chantelle Bell
Managing Director of Syrona Health
Chantelle Bell is the Managing Director and co-founder of Syrona Health.
Follow Chantelle Bell:
About Syrona Health: Syrona Health is a personalised digital health platform for Chronic Gynaecological/Uterine Conditions like Endometriosis, PCOS etc.
Ian Warwick
Director of Liverpool ChiroChem
Ian Warwick is the Managing Partner at Deepbridge Capital LLP.
Follow Ian Warwick:
About AlgaeCytes, arbnco Limited, Deepbridge Capital, Liverpool ChiroChem: Liverpool ChiroChem manufactures and supplies specialist building blocks for pharmaceutical research and biotechnology.
James Fleet
Executive Director & Consulting Partner of Four Eyes Insight
James is a clinical workforce efficiency specialist. James has significant experience in clinical workforce productivity and transformation within Health and works closely with Hospitals to secure sustainable efficiency improvements, optimum productivity and high levels of performance. James has previously worked within the NHS as an Executive Director and also led PwC’s health workforce consulting team, which involved him working with a large range of FT’s and Trust’s, as well as the Department of Health and NHS regulators – Monitor, NTDA and the CQC. James has led the delivery of major efficiency and productivity programmes, with huge success.
Follow James Fleet:
About Four Eyes Insight: Four Eyes Insight is a medical productivity and clinical service consultancy, founded in 2013.
Kayley Taggart
Regional Director of Four Eyes Insight
Kayley is the Director of Delivery for Four Eyes Insight and has worked across the public sector for 10 years. Kayley has a strong NHS operational management background, having recently been the General Manager for Surgery at Guys and St Thomas’ NHS Foundation Trust. Here Kayley led the team to achieve RTT, performance and efficiency targets in Orthopaedics, ENT and Plastic Surgery. Kayley also led the transformation of administrative services and patient pathways within the Trust. Kayley has an excellent approach to clinical engagement and exceptional interpersonal skills, which enable Kayley to ‘take clinicians with her’. Kayley has previously operated as Service Manager for The Elective Orthopaedic centre and is currently studying at Westminster University for the Exec. MBA.
Follow Kayley Taggart:
About Four Eyes Insight: Four Eyes Insight is a medical productivity and clinical service consultancy, founded in 2013.
Clare Baldwin
Regional Director of Four Eyes Insight
Clare is a Delivery Director at Four Eyes Insight with a strong background in NHS hospital operational management. Clare has worked in the NHS for 18 years as a service and quality focused NHS Manager with clinical leadership experience, able to form positive and effective working relationships with management and clinical teams of all skill levels. Clare’s track record is one of delivering key targets including the turnaround of RTT and cancer performance in a number of large, complex organisations. Clare has very strong analytical skills with an ability to identify information requirements, analyse data and form conclusions which contribute to the development of well planned, deliverable actions that achieve set objectives.
Follow Clare Baldwin:
About Four Eyes Insight: Four Eyes Insight is a medical productivity and clinical service consultancy, founded in 2013.
Henry Carleton
Director of Technology & Innovation of Four Eyes Insight
Henry is a trained doctor with extensive hospital experience who co-founded Four Eyes Insight to put his talent for finding strategic solutions and planning into helping the NHS. His interest in medical resource management developed during his junior doctor training at Bart’s and the Royal London and he helped trusts tackle the significant challenges of rotas and the New Deal as Junior Doctors’ Advisor at the London Regional Action Team. Establishing Zircadian Ltd, a software development company focusing on a portfolio of solutions to help NHS organisations plan and organise their medical workforce more strategically and effectively in 2000, he sold it on 11 years later to Allocate with over 140 NHS clients using its products.
Follow Henry Carleton:
About Four Eyes Insight: Four Eyes Insight is a medical productivity and clinical service consultancy, founded in 2013.
Brian Wells
Executive Director of Strategic Development of Four Eyes Insight
Brian trained as a Registered Nurse before specialising in theatres and anaesthetics, having a long clinical career before moving into management. Working for the Health Service inspectors, the Audit Commission and the Healthcare Commission, he led service improvement programmes across London healthcare organisations. Brian was most recently Director of Orthopaedics at Guy’s and St Thomas’ NHS Foundation Trust where he provided senior leadership in the development and implementation of a new service delivery model for its elective orthopaedic services. His focus on medical workforce productivity, process standardisation and operational grip helped the clinical leadership deliver its high quality service in a sustainable way. Brian is a co-founder of Four Eyes Insight and has a BSc (Hons) degree in Health Studies and the Executive MBA.
Follow Brian Wells:
About Four Eyes Insight: Four Eyes Insight is a medical productivity and clinical service consultancy, founded in 2013.
Justin James
Buying and Merchandising Director of MedicAnimal.com
Follow Justin James:
About MedicAnimal.com: MedicAnimal.com is an e-commerce company specializing in veterinary and pet retail.
Bijendra Patel
Director of Surgical Skills and Science of Barts Cancer Institute
Follow Bijendra Patel:
About Barts Cancer Institute, Barts Health NHS Trust: Barts Cancer Institute (BCI) is one of the top cancer research centres in the UK.
Samantha Perona
CEO, Founder & Director of Perfectus Biomed
Experienced Chief Executive Officer, PhD, MSC with a demonstrated history of working in commercial research. Skilled in Good Laboratory Practice (GLP), ISO 9001 and 17025. Experience with FDA 510K data generation and MDD/MDR compliance. Strong business development professional with a Goldman Sachs 10,000 small businesses focused in Business.
Follow Samantha Perona:
About Perfectus Biomed: Perfectus Biomed is a U.K.-based biotechnology company providing microbiological services.
Amit Patel
Director of New Ventures of Bupa
Amit Patel serves as the director of New Ventures at Bupa. He is an intrapreneur responsible for incubating, testing and scaling innovative and compelling customer propositions. He is a start-up advisor and a tech enthusiast with keen interest in exponential technologies (e.g. Blockchain / DLT, ML / AI etc) and their application in healthcare and insurance. Previously, Amit has held several Senior Roles at Bupa including Strategy & M&A Director for Bupa UK. Prior to Bupa, he worked as a Strategy Consultant at LEK – a top tier Strategy Consulting firm – advising Fortune 500 companies and private equity investors on growth strategy and M&A. Amit started his career in Medicine and trained as a General Surgeon working in the NHS.
Follow Amit Patel:
About Bupa: Bupa is an international healthcare group, serving over 22 million customers in over 190 countries.
Apostolos Papadopoulos
Managing Director of Crop Intellect
Dr. Apostolos Papadopoulos founded Crop Intellect in November 2011, since which he has been serving as its managing director.
Follow Apostolos Papadopoulos:
About Crop Intellect: Crop Intellect operates a research and development company that develops agricultural technologies that improves crop productivity.
Matt Worrall
Associate Director, Policy & Communication – Oncology of MSD
Matt has more than a decade of healthcare media relations and public affairs experience gained across medical professional bodies, NHS and provider sector. Before joining Portland he was a public affairs executive at ABPI and was Head of Communications at the Royal College of Surgeons. He saw the College through its engagement with the Health & Social Care Act 2012 and high-profile campaigning for the relaxation of the European Working Time Directive. Among his clients in recent years have been the NHS National Screening Committee, NHS England, BMI Healthcare, HCA International, Lilly, Amgen, UCB, Mundipharma, Apple and Alexion.
Follow Matt Worrall:
About MSD: MSD is a leading global biopharmaceutical company that provides medicines, vaccines, biologic therapies, and animal health products.
Ian Abercrombie
Business Unit Director & Chief Operating Officer of NuCana BioMed
Ian Abercrombie has over 25 years experience in the biopharmaceutical and healthcare industry. Ian’s specific expertise includes the clinical development and commercialisation of anti-cancer medicines and companion diagnostics to enable therapies to be targeted to specific patient populations. Ian has wide biopharmaceutical and healthcare experience having initially served in the public health sector before working for Janssen Cilag, Ortho-Biotech, Bioenvision and Caris Life Sciences. Whilst at Bioenvision, Ian played a major role in developing and commercialising clofarabine, the first new drug to be approved specifically for childhood acute leukaemia in Europe for over thirty years.
Follow Ian Abercrombie:
About Medannex Ltd, NuCana BioMed: NuCana BioMed, a biopharmaceutical company, develops and commercializes rationally designed medicines for significant unmet medical needs.
Roddy Morrison
Supply Chain Director of MESM
Roddy Morrison is the Supply Chain Director at MESM with responsibility for the UK and US Operations. Roddy has spent over 25 years working in the Pharmaceutical and Consumer Goods sectors in various procurement and supply chain roles the most recent being 2 years with Unilever as the Head of Supply Chain Refrigeration Solutions. Roddy is passionate in developing new and innovative methods of supply to ensure that we are able to meet our current and future customer needs.
Follow Roddy Morrison:
About MESM: MESM a provider of laboratory and medical equipment and ancillary supplies to clinical trials worldwide.
David Maughan
Managing Director of MESM
David Maughan is the Chairman and President of MESM. Prior to co-founding the business 9 years ago, David spent 30+ years as a procurement professional within the automotive industry. His final position as Procurement Director at Bentley allowed him to bring the culture and behaviours of a company focussed on both innovation and customer experience and apply them to the clinical trial equipment supply industry. By using this approach, David has historically lead the rapid growth of MESM based on its ability to deliver on its promises and he is looking forward to seeing the continued expansion of the business under David Parry’s leadership.
Follow David Maughan:
About MESM: MESM a provider of laboratory and medical equipment and ancillary supplies to clinical trials worldwide.
John Bernard
Marketing Director, EMEA of Dexcom
John Bernard EMEA Marketing Director UK Marketer of the Year 2013. Marketing ‘Vision 100’ 2014. Shortlisted ‘Digital Marketer of the Year 2014’. Founder (1996) and CEO of successful housing start-up sold in 2007. Investor. Board Member x 2.A multiple award-winning, commercially focused marketer, with an ability to use customer insight to create powerful marketing solutions. A bright, confident and self-motivated individual with a track record of using marketing to exceed specified global annual targets of over €1 billion revenue. Henley MBA qualified, with over 20 years’ telecoms, media and technology experience. Speciality of launching products into market using advertising, PR, product marketing, digital, channel activity and sponsorship. Over ten years’ experience of managing marketing budgets of over £15m successfully to exceed sales targets. Not just experience with old-school marketing, though. Expert online marketer who know how to create a buzz through inbound marketing or viral traffic through the web, social media and content discovery. Writing a good press release just doesn’t cut it anymore so now also an industry blogger who understands how the current state of the web operates and knows how to make it work. Enjoy working at both the strategic and tactical levels, developing people and teams, owning and improving business performance both internationally and within the UK. Currently the EMEA Marketing Director of Dexcom.
Follow John Bernard:
About Dexcom, MENA Digital Awards: Dexcom develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management.
Rebecca Woodley-Jones
Commercial Director of Swellaway
Follow Rebecca Woodley-Jones:
About Swellaway: Swellaway is manufactures electronic medical rehabilitative device which offers wireless/mobile patient monitoring.
Jouni Vikman
Sales Director of Westfield Medical
Jouni Vikman currently serves Westfield Medical as a sales director. Prior to joining Westfield Medical, Jouni spent 14 years with the Wipak as health director, business manager, product manager, and R&D engineer. Jouni holds a masters degree in materials science from the Tampere University of Technology.
Follow Jouni Vikman:
About Westfield Medical: Westfield Medical is a provider of sterilisation barrier products to the healthcare and industrial sectors.
Oriane Chausiaux
Founder Director – CSO, Serial Entrepreneur of Heartfelt Technologies
Follow Oriane Chausiaux:
About Heartfelt Technologies: Heartfelt Technologies are developing the only home-based heart failure monitor that does not require patient interaction or compliance.
Liam Mcquillan
Director of Liopa
Follow Liam Mcquillan:
About Catalyst, Liopa: Liopa’s LipRead deciphers speech from lip movements. It uses AI and deep learning for automated lip reading.
Bruce Renfrew
Managing Director of Renfrew Group International
Follow Bruce Renfrew:
About Renfrew Group International: Award winning Renfrew Group are a full service, product design consultancy.
Dominic Farmer
Managing Director of Cisiv
Dominic Farmer has over 25 years experience in both healthcare technology and observational research. He set up Cisiv to provide technologies for use in real world research following extensive experience with leading global Pharma companies in the software development and implementation of large-scale global studies.
Follow Dominic Farmer:
About Cisiv: Cisiv is a developer of technology solutions for pharmaceutical companies.
Ruth Whittaker
Finance and Admin Director of Cisiv
Follow Ruth Whittaker:
About Cisiv: Cisiv is a developer of technology solutions for pharmaceutical companies.
Ian Fotheringham
Managing Director of Ingenza
Ian Fotheringham received a PhD in molecular biology from the University of Glasgow, UK, in 1986. He joined the NutraSweet division of Monsanto in Chicago, USA, constructing microbes to produce the Aspartame® sweetener. From 1993, he continued developing large-scale bioprocesses with NSC Technologies and Great Lakes Fine Chemicals. Ian co-founded Ingenza in 2003, has published 35 papers and articles, and holds eight current patents.
Follow Ian Fotheringham:
About Ingenza: Ingenza is an industrial biotechnology company.
